Main > > >INFARCTION.

Acute Coronary Syndrome (ACS). Non-ST (Stent Thrombosis) Elevation (NSTE-ACS).
Rate of Thrombotic CardioVascular Events (combined endpoint of death, myocardial infarction, or refractory ischemia/re- peat cardiac procedure). Reduction:
Tirofiban.HCl Inj. High-Dose Bolus (HDB)
Brand.
CA Approval Date : 2017. 07.17.
USA Approval Date: 2016. 09.01.
(*) Company : Medicure Inc.
Patent : Expired.
TradeMark: Aggrastat
Web-Site :
www.medicure.com/aggrastat
UpDate: 2019. 02.18.




Cardio.>Aspirin. MI Prevention? Compa- nion DIAG.:
11-DeHydro Thromboxane B2 ELISA Urine
Test.
USA Approval Date: 2007. 05.29.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2019. 03.18.




Cardio.>Aspirin+OmeprAzole Delayed Release Tablets.
Indications:
Aspirin Component:
. Reducing the combined risk of death
and nonfatal MI in patients with a
previous MI or unstable angina
pectoris
. Reducing the combined risk of MI and
sudden death in patients with chronic
stable angina pectoris
. Use in patients who have undergone
revascularization procedures (Coronary
Artery Bypass Graft [CABG] or
Percutaneous Transluminal Coronary
Angioplasty [PTCA]) when there is a
pre-existing condition for which
aspirin is already indicated
OmeprAzole Component:
. decreasing the risk of developing
aspirin-associated gastric ulcers in
patients at risk for developing
aspirin-associated gastric ulcers due
to age (≥ 55) or documented history of
gastric ulcers.
USA Approval Date: 2016. 09.15.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2019. 03.18.




Cardio.>Coronary Artery Disease. Lipid Core Plaque (LCP). Detection & Analysis. IntraVascular UltraSound (IVUS)+Near InfraRed Spectroscopy (NIRS). Heart Attack (Myocardial Infarction) Prognos- tics.
JP Approval Date : 2017. 08.
JP Launch Date : 2018. 07.31.
USA Approval Date: ?
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2019. 04.11.




Cardio.>History of MI (Myocardial Infarc tion). Reduction of Thrombotic CV Events.
USA Approval Date: 2014. 05.08.
USA Launch Date: 2017. 06.07.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2019. 04.17.




Cardio.>HyperTriGlyceridemia. (HTG). Icosapent Ethyl [Ethyl EicosaPentaenoic Acid (E-EPA)]. Indications:
Indication (1): HTG>Treat.>Diet+ Icosa-
pent Ethyl Capsules.
Indication (2): CardioVascular (CV)
Events (in Adult Pa-
tients with HTG & CV
DIS. or Diabetes) RISK
Reduction: Statin+Icosa-
pent Ethyl Capsules.
CV Events:
- Coronary Revascularization.
- Myocardial Infarction (MI)
- Stroke
- Unstable Angina requiring hospitali-
zation.
CA Approval Date (2): 2020. 01.02.
USA Approval Date (1): 2012.
USA Approval Date (2): 2019. 12.13.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2020. 01.03.




Cardio.>Myocardial Infarction. Acute. Infarct Size Reduction: Impulse Catheter System.
Used during PCI.
Acute MI=anterior STEMI.
EU CE Mark Date: 2020. 06.23.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2020. 09.08.




Cardio.>Myocardial Infarction. Acute. Left Anterior Descending ST-Segment Elevation Myocardial Infarction (LAD-STEMI). Treat.: Super Saturated O2 (SSO2) 2nd Generation (G) Reduce Heart Muscle Damage Following Angioplasty and Stenting.
EU Approval Date: 2020. 05.04.
USA Approval Date: 2020. 03.30.
(*) Company; Patent & Web-Sites Avai-
lable on Request.
UpDate: 2020. 09.11.




Cardio.>Myocardial Infarction. Acute. TREAT. Reduction of Mortality of Hemodynamically Stable Patients Within 24 Hours: Lisinopril Oral Solution.
USA Approval Date: 2016. 07.29.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2019. 07.14.




Cardio.>Myocardial Infarction. DIAG.:
High Sensitivity Troponin I Assay.
AU; CL & EU Launch Date: 2019. 04.16.
(*) Company; Patents; PR Web-Site &
TradeMark Available on Request.
UpDate: 2019. 08.25.




Cardio.>Myocardial Infarction. Preven-tion. Diabetes Type II Patients: Semaglutide.
USA Approval Date: 2020. 01.16.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2020. 01.18.







>INFARCTION.'s products
This section has no products